期刊文献+

分化型甲状腺癌的外科治疗分析 被引量:2

Surgical Treatment Analysis of Cifferentiated Thyroid Cancer
下载PDF
导出
摘要 目的探讨分化型甲状腺癌的外科治疗的疗效。方法参照分化型甲状腺癌的危险性评估,不同患者的手术采用不同的切除范围。结果 128例分化型甲状腺癌术后5年生存率为100%,10年生存率97.7%。结论甲状腺癌的规范手术决定了患者的预后,采用适当的手术方式,同时加强术后的治疗,可明显提高生存率。 Objective To analyze the efficacy of surgical treatment of differentiated thyroid cancer. Methods Reference to differen- tiated thyroid cancer risk assessment, different patients used different operation resection range. Results 5-year survival rate of 128 patients with differentiated thyroid cancer was 100%, 10-year survival rate was 97.7%. Conclusion The specification of the thyroid cancer surgery range determined the prognosis of patients, using appropriate surgical approach and strengthening the post- operative follow-up treatment could improve survival.
出处 《中外医疗》 2013年第4期6-6,8,共2页 China & Foreign Medical Treatment
关键词 分化型甲状腺癌 外科治疗 恶性肿瘤 Differentiated thyroid cancer Surgical treatment
  • 相关文献

参考文献4

二级参考文献19

  • 1Brunt LM, Wells SA Jr. Advances in the diagnosis and treatment of medullary thyroid carcinoma [J].Surg Clin North Am,1987,67(2):263-279.
  • 2李树玲.头颈肿瘤学[M].天津:天津科学技术出版社,1995.752.
  • 3Belli S, Storani ME, Dourisboure RJ, et al. Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers[J]. Medicina (B Aires), 2003, 63(1):41-45. Spanish.
  • 4Cohen R,Campos JM,Salaun C,et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC)[J]. J Clin Endocrinol Metab, 2000, 85(2):919-922.
  • 5Schilling T, Burck J, Sinn HP, et al. Prognostic value of codon 918 (ATG→ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma[J]. Int J Cancer,2001,95(1):62-66.
  • 6Dralle H, Gimm O, Simon D, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience[J]. World J Surg, 1998, 22(7):744-750; discussion 750-751.
  • 7van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma[J]. Ann Surg, 1990, 212(4):395-400; discussion 400-401.
  • 8Jensen MH, Davis RK, Derrick L. Thyroid cancer: a computer-assisted review of 5287 cases[J]. Otolaryngol Head Neck Surg, 1990, 102(1):51-65.
  • 9Erdem E, Gulcelik M A, Kuru B, et al. Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma[J]. Eur J Surg Oncol, 2003, 29(9): 747.
  • 10Cohen E G, Tuttle R M, Kraus D H. Postoperative management of differentiated thyroid cancer[J]. Otolaryngol Clin North Am, 2003, 36(1): 129.

共引文献25

同被引文献21

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部